Market research
ALUR Allurion Technologies, Inc.
NYSE USD Healthcare
Latest close
As of 15 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6K
- P/E ratio
- Not available
- Analyst target
- 82.5
- Dividend yield
- Not available
- Beta
- -0.13
Profile
Instrument facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- Not available
- Market cap
- 6K
- P/E ratio
- Not available
- Analyst target
- 82.5
- Dividend yield
- Not available
- Beta
- -0.13
About
About Allurion Technologies, Inc.
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
Research context
Allurion Technologies, Inc. appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
0 comments
Sign in to join the ALUR discussion.
No comments yet
Start a focused discussion about ALUR.